Rosacea has historically been a very challenging to treat dermatologic condition however recent breakthroughs    Roy G. Geronemus, MD in laser and light therapy have allowed clinicians to much more effectively treat and manage some of the different aspects of the disease, bringing much needed hope for this patient population. A number of medications are currently being used to successfully treat and manage the clinical symptoms of papulopustular rosacea. Many of these patients however will also have clinical symptoms of erythematotelangiectatic rosacea typically characterized by diffuse and persistent facial erythema and telangiectasias, according to according to Roy G. Geronemus M.D., clinical professor of the Department of Dermatology at NYU Medical Center and Director of the Laser & Skin Surgery Center of New York. The vascular component of rosacea has always been particularly difficult to treat and while pulsed dye lasers and IPL (intense pulsed light) devices have been shown to be useful in improving these symptoms, more recent advances in laser and light therapy are proving to be very effective in the treatment and management of erythematotelangiectatic rosacea, he notes. Dr. Geronemus  recently spoke at the 10th annual Laser & Aesthetic Skin Therapy course in Boston. Read more at Dermatology Times.